Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function
Cervix Neoplasms, Endometrial Cancer, Adenomyosis
About this trial
This is an interventional supportive care trial for Cervix Neoplasms
Eligibility Criteria
Inclusion Criteria:
- patients who were scheduled for laparoscopic hysterectomy from W&C BRANCH HOSPITAL OF JIANGSU PROVINCE HOSPITAL
- American Society of Anesthesiologists (ASA) physical status classification 1 to 2,
- Women aged 40-65
- Weight 50-80 kg
Exclusion Criteria:
- History of opioids abuse and allergy and contraindication to opioid drugs
- bronchial asthma; coronary heart disease; severe hypertension; diabetes mellitus;
- hepatic, and renal dysfunction (glutamyl aminotransferase> 40U or aspartate aminotransferase> 35U; urea nitrogen> 8.2 μmol / L, creatinine> 133 μmol / L),
- History of brain damage or psychiatric disease
- Patients with coagulopathy (PT> 17 seconds or activated partial thromboplastin time (APTT)> 47 seconds);
- pregnant or lactating women;
- Those with long-term constipation;
- History of digestive diseases;
- history of gastrointestinal disease (peptic ulcer disease, Crohn's disease, or ulcerative colitis)
- Participants in other drug trials in the past three months. (11)After randomization and allocation, patients were withdrawn if laparoscopy was converted to open surgery or if they required reinvestigation for postoperative bleeding.
Sites / Locations
- The First Affiliated Hospital with Nanjing Medical UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
Fentanyl group(group F)
Oxycodone group(group O)
Butorphanol group(group B)
Fentanyl citrate injection, specification: 10mL: 0.5mg / piece (production unit: niching chang rendu Pharmaceutical Co., Ltd., valid period: 48 months) For group F patients,0.5mg fentanyl was mixed with saline to a total volume of 100mL; continuous infusion was set to 2mL/h, a bolus dose of 3mL, and a lockout interval of 15 minutes
Oxycodone hydrochloride injection, specification: 1mL: 10mg / branch (production unit: HAMOL LIMITED, valid period: 60 months) For group O patients,30mg oxycodone was mixed with saline to a total volume of 100mL; continuous infusion was set to 2mL/h, a bolus dose of 3mL, and a lockout interval of 15 minutes
Butorphanol tartrate injection, specification: 1 mL: 1 mg / branch (production unit: Jiangsu henryi Pharmaceutical Co., Ltd., valid period: 24 months); For group B patients,10mg butorphanol was mixed with saline to a total volume of 100mL; continuous infusion was set to 2mL/h, a bolus dose of 3mL, and a lockout interval of 15 minutes